These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16892910)

  • 21. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis.
    Rücker G; Schwarzer G; Carpenter JR; Binder H; Schumacher M
    Biostatistics; 2011 Jan; 12(1):122-42. PubMed ID: 20656692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hypothesis test for the end of a common source outbreak.
    Brookmeyer R; You X
    Biometrics; 2006 Mar; 62(1):61-5. PubMed ID: 16542230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active immunisation during an outbreak of hepatitis A in a German day-care centre.
    Hauri AM; Fischer E; Fitzenberger J; Uphoff H; Koenig C
    Vaccine; 2006 Jul; 24(29-30):5684-9. PubMed ID: 16730103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological characteristics of reported sporadic and outbreak cases of E. coli O157 in people from Alberta, Canada (2000-2002): methodological challenges of comparing clustered to unclustered data.
    Pearl DL; Louie M; Chui L; Doré K; Grimsrud KM; Martin SW; Michel P; Svenson LW; McEwen SA
    Epidemiol Infect; 2008 Apr; 136(4):483-91. PubMed ID: 17565768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of vaccine efficacy and the vaccination threshold.
    Yip PS; Watson R; Chen Q
    Stat Med; 2007 Oct; 26(24):4475-88. PubMed ID: 17348084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Household transmission of SARS, 2003.
    Wilson-Clark SD; Deeks SL; Gournis E; Hay K; Bondy S; Kennedy E; Johnson I; Rea E; Kuschak T; Green D; Abbas Z; Guarda B
    CMAJ; 2006 Nov; 175(10):1219-23. PubMed ID: 17098951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new method for estimating the size of small populations from genetic mark-recapture data.
    Miller CR; Joyce P; Waits LP
    Mol Ecol; 2005 Jun; 14(7):1991-2005. PubMed ID: 15910321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling disease-state transition heterogeneity through Bayesian variable selection.
    Healy BC; Engler D
    Stat Med; 2009 Apr; 28(9):1353-68. PubMed ID: 19206077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of committed individuals on vaccination behavior.
    Liu XT; Wu ZX; Zhang L
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Nov; 86(5 Pt 1):051132. PubMed ID: 23214763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simulation study to assess statistical methods for binary repeated measures data.
    Masaoud E; Stryhn H
    Prev Vet Med; 2010 Feb; 93(2-3):81-97. PubMed ID: 20004989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Number-needed-to-vaccinate calculations: fallacies associated with exclusion of transmission.
    Tuite AR; Fisman DN
    Vaccine; 2013 Jan; 31(6):973-8. PubMed ID: 23246262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling spatial heterogeneity of disease risk and evaluation of the impact of vaccination.
    Ali M; Emch M; Yunus M; Clemens J
    Vaccine; 2009 Jun; 27(28):3724-9. PubMed ID: 19464555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.
    Datta S; Halloran ME; Longini IM
    Biometrics; 1999 Sep; 55(3):792-8. PubMed ID: 11315008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating and interpreting secondary attack risk: Binomial considered biased.
    Sharker Y; Kenah E
    PLoS Comput Biol; 2021 Jan; 17(1):e1008601. PubMed ID: 33471806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Household structure and infectious disease transmission.
    House T; Keeling MJ
    Epidemiol Infect; 2009 May; 137(5):654-61. PubMed ID: 18840319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines.
    Longini IM; Hudgens MG; Halloran ME; Sagatelian K
    Stat Med; 1999 Jan; 18(1):53-68. PubMed ID: 9990692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing epidemics in a community of households.
    Hall R; Becker NG
    Epidemiol Infect; 1996 Dec; 117(3):443-55. PubMed ID: 8972668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging Pathogen Sequence and Contact Tracing Data to Enhance Vaccine Trials in Emerging Epidemics.
    Kahn R; Wang R; Leavitt SV; Hanage WP; Lipsitch M
    Epidemiology; 2021 Sep; 32(5):698-704. PubMed ID: 34039898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On estimation of vaccine efficacy using validation samples with selection bias.
    Scharfstein DO; Halloran ME; Chu H; Daniels MJ
    Biostatistics; 2006 Oct; 7(4):615-29. PubMed ID: 16556610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.